Virus News and Research

Latest Virus News and Research

FDA issues new guidance to reduce risk of Zika blood transmission

As a safety measure against the emerging Zika virus outbreak, today the U.S. Food and Drug Administration issued a new guidance recommending the deferral of individuals from donating blood if they have been to areas with active Zika virus transmission, potentially have been exposed to the virus, or have had a confirmed Zika virus infection.

18 Feb 2016

WRAIR begins Phase 1 clinical trial to evaluate MERS vaccine candidate

The Walter Reed Army Institute of Research began vaccinations today in a Phase 1 clinical trial to evaluate the safety and immune response of a vaccine candidate to prevent Middle East Respiratory Syndrome (MERS).

17 Feb 2016

New staging system proposed to identify most appropriate treatments for HPV-related OPC

Human papillomavirus (HPV) status is a strong predictor of prognosis for patients with oropharyngeal carcinoma (OPC), but the current staging system does not adequately account for biological and clinical differences between HPV-positive OPC and HPV-negative OPC, commonly caused by alcohol and tobacco use.

17 Feb 2016

Zika virus isn't stopping Americans from making international travel plans, study finds

Global concerns about Zika virus aren't stopping Americans from making international travel plans, a new study finds, but many who do plan to go abroad say they want more information about the virus.

17 Feb 2016

Electronic health records could help identify people who have undiagnosed type 2 diabetes

In 2012, a group of UCLA researchers set out to mine thousands of electronic health records for a more accurate and less expensive way to identify people who have undiagnosed type 2 diabetes. The researchers got much more than they bargained for.

16 Feb 2016

UAB research reveals heterogonous population of leukemia stem cells

University of Alabama at Birmingham researchers have found a marker on blood cells that may help the most pressing problem in chronic myelogenous leukemia, or CML, today — an inability to get patients off treatment.

16 Feb 2016

NAU researcher calls for greater public awareness of cytomegalovirus

As the Zika virus continues to spread across the globe, and gain worldwide attention for its' potential birth defects, an NAU researcher is calling for greater public awareness of cytomegalovirus—the most common viral cause of birth defects in the United States.

16 Feb 2016

Johns Hopkins experts provide useful information to help prevent transmission of Zika virus

With Zika virus emerging as a public health concern worldwide, experts at The Johns Hopkins Hospital are closely monitoring the spread of the mosquito-borne illness and offering useful information to help prevent transmission.

16 Feb 2016

CMV-based vaccine provides protection against Ebola virus

As the latest in a series of studies, researchers at Plymouth University, National Institutes of Health and University of California, Riverside, have shown the ability of a vaccine vector based on a common herpesvirus called cytomegalovirus (CMV) expressing Ebola virus glycoprotein (GP), to provide protection against Ebola virus in the experimental rhesus macaque, non-human primate (NHP) model.

16 Feb 2016

Experimental vaccine shows effectiveness in Ebola vaccine trial

An experimental vaccine combined with an innovative way of vaccinating people has resulted in an estimated 100 percent efficacy of the vaccine against the Ebola virus in West Africa -- and the approach could establish a new way of responding to outbreaks of emerging pathogens, including the Zika virus.

16 Feb 2016

RB announces Zika Relief Package of $1 million to help fight Zika virus outbreak

In response to the global call for urgently needed resources to fight the spread of the Zika virus, RB is announcing a Zika Relief Package of $1 million USD consisting of both cash and product donations that will be made available to health authorities and international NGOs battling the outbreak.

16 Feb 2016

UF study shows effective way to control damaging health impacts of mosquito-borne diseases

A common toxin used to kill yellow fever mosquito larvae - the most prevalent transmitter of dengue, chikungunya and zika viruses - is highly effective. While there are some fitness advantages to surviving adults, this is still an effective way to control the damaging health impacts of these mosquito-borne diseases, a new University of Florida study shows.

15 Feb 2016

Wake Forest Baptist researchers develop new nanotechnology to detect disease biomarkers

Researchers at Wake Forest Baptist Medical Center have developed a new technology to detect disease biomarkers in the form of nucleic acids, the building blocks of all living organisms.

15 Feb 2016

Scientists modify plants' defense system to confer resistance to virus

Scientists at Indiana University have modified a plant gene that normally fights bacterial infection to confer resistance to a virus.

15 Feb 2016

Protein Sciences, UNIGEN agree to supply Flublok influenza vaccine for the U.S. market from Japan

Protein Sciences Corporation (Meriden, CT and Pearl River, NY) and UMN Pharma Inc. (Akita, Akita prefecture, Japan) announced today that Protein Sciences and UNIGEN Inc., a joint venture of UMN and IHI Corporation (Koto-ku, Tokyo, Japan), entered into an agreement to source bulk Flublok influenza vaccine from Japan for the U.S. market.

12 Feb 2016

Virus News and Research

Latest Virus News and Research

FDA issues new guidance to reduce risk of Zika blood transmission

WRAIR begins Phase 1 clinical trial to evaluate MERS vaccine candidate

New staging system proposed to identify most appropriate treatments for HPV-related OPC

Zika virus isn't stopping Americans from making international travel plans, study finds

Electronic health records could help identify people who have undiagnosed type 2 diabetes

UAB research reveals heterogonous population of leukemia stem cells

NAU researcher calls for greater public awareness of cytomegalovirus

Johns Hopkins experts provide useful information to help prevent transmission of Zika virus

CMV-based vaccine provides protection against Ebola virus

Experimental vaccine shows effectiveness in Ebola vaccine trial

RB announces Zika Relief Package of $1 million to help fight Zika virus outbreak

UF study shows effective way to control damaging health impacts of mosquito-borne diseases

Wake Forest Baptist researchers develop new nanotechnology to detect disease biomarkers

Scientists modify plants' defense system to confer resistance to virus

Protein Sciences, UNIGEN agree to supply Flublok influenza vaccine for the U.S. market from Japan

Tick genome study sheds light on occurrences of Lyme disease

Leading global health bodies share data related to Zika crisis

Leeds scientists to start computer drug research to find cure for Ebola virus

Zika: an update

Unlocking intrinsically disordered proteins: an interview with Peter Wright

A new way of characterising biomolecules eBook

The CAR T Veteran: A Journey of Resilience, Remission, and Advocacy

Innovating for impact: Jordi Labs on aligning methodologies with FDA expectation

Exploring the role of confocal-based high-content imaging in advancing core facilities

Virus News and Research

Latest Virus News and Research

A new way of characterising biomolecules eBook

The CAR T Veteran: A Journey of Resilience, Remission, and Advocacy

Innovating for impact: Jordi Labs on aligning methodologies with FDA expectation

Exploring the role of confocal-based high-content imaging in advancing core facilities

Newsletters you may be interested in